Vertex Pharmaceuticals (NASDAQ:VRTX – Get Free Report) had its price target hoisted by Royal Bank of Canada from $402.00 to $407.00 in a research note issued to investors on Tuesday,Benzinga reports.

Royal Bank of Canada closed 6.3% below its 52-week high of C$180.45, which the company achieved on December 6th.

Royal Bank is up 28% in the past year. Are more gains on the way? The post Outlook for Royal Bank of Canada Stock in 2025 ...

Shares of Royal Bank of Canada RY slipped 0.26% to C$170.44 Friday, in what proved to be an all-around negative trading ...

Royal Bank of Canada (NYSE:RY – Get Free Report) (TSE:RY) has been assigned a consensus rating of “Buy” from the seven ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

The bank also warned that retaliatory tariffs by Canada and other nations against the U.S. if Donald Trump imposes tariffs could cause a period of inflation.

In a report released yesterday, Douglas Young from Desjardins maintained a Buy rating on Royal Bank Of Canada (RY – Research Report), with a ...